Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-011283
Filing Date
2025-04-24
Accepted
2025-04-24 16:08:28
Documents
1
Period of Report
2025-04-22

Document Format Files

Seq Description Document Type Size
1 form4-04242025_080425.html 4  
1 form4-04242025_080425.xml 4 4840
  Complete submission text file 0001415889-25-011283.txt   6314
Mailing Address 501 CANAL BLVD. RICHMOND CA 94084
Business Address 501 CANAL BLVD. RICHMOND CA 94084 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 721 ST. GEORGES ROAD PHILADELPHIA PA 19119
Business Address
Macrae Sandy (Reporting) CIK: 0001675687 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 25867360